Kawasaki disease and immunodeficiencies in children: case reports and literature review
Kawasaki disease (KD) has features that appear supporting an infectious cause with a secondary deranged inflammatory/autoimmune response. The association of KD in adults with human immunodeficiency virus infection and the presence of KD in patients with immunodeficiency disorders support the infecti...
Gespeichert in:
| Veröffentlicht in: | Rheumatology international 2019-10, Vol.39 (10), p.1829-1838 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1838 |
|---|---|
| container_issue | 10 |
| container_start_page | 1829 |
| container_title | Rheumatology international |
| container_volume | 39 |
| creator | Rivas-Larrauri, Francisco Aguilar-Zanela, Lorena Castro-Oteo, Paola Rosales-Hernandez, Luis Adrian Otero-Mendoza, Francisco López-Herrera, Gabriela Ordoñez-Ortega, Javier Garrido-García, Martín Yamazaki-Nakashimada, Marco Antonio |
| description | Kawasaki disease (KD) has features that appear supporting an infectious cause with a secondary deranged inflammatory/autoimmune response. The association of KD in adults with human immunodeficiency virus infection and the presence of KD in patients with immunodeficiency disorders support the infectious theory. We present four KD patients associated with immunodeficiencies: one with X-linked agammaglobulinemia, one with HIV infection, and two with leukemia; one of these patients also had Down syndrome. We did a literature search to find out all reported cases of immunodeficiency with KD in children. In immunodeficiency disorders, the inability of the immune system to eradicate the pathogens coupled to an exaggerated inflammatory response, especially in chronic granulomatous disease, may lead to the development of KD. The study of patients with immunodeficiencies complicated with KD may shed light into the etiopathogenesis of the disease. |
| doi_str_mv | 10.1007/s00296-019-04382-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2259358945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2258484747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-334ab57721f83077006e2ba1ef44725ff4c8b131998fe687d88af2f845b064973</originalsourceid><addsrcrecordid>eNp9kTlPxDAQhS0EguX4AxQoEg1NYHwkdujQiksg0YCgs5xkDIYci52w4t_jZTkkCgqPZc_33oz0CNmlcEgB5FEAYEWeAi1SEFyxdL5CJlRwmdIcHlbJBKhkqYplg2yG8AzxneewTjY45ZQpJSfk_srMTTAvLqldQBMwMV2duLYdu75G6yqHXTwhcV1SPbmm9tgdJ9UC9Djr_RA-BY0b0Jth9IvvN4fzbbJmTRNw5-veIndnp7fTi_T65vxyenKdVgL4kHIuTJlJyahVHKQEyJGVhqIVQrLMWlGpMi5bFMpirmStlLHMKpGVkItC8i1ysPSd-f51xDDo1oUKm8Z02I9BM5YVPFOFyCK6_wd97kffxe00ywshhYrgvxTLlFARXIxlS6ryfQgerZ551xr_rinoRTh6GY6O4ejPcPQ8iva-rMeyxfpH8p1GBPgSCLHVPaL_nf2P7Qcwa5kS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258484747</pqid></control><display><type>article</type><title>Kawasaki disease and immunodeficiencies in children: case reports and literature review</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Rivas-Larrauri, Francisco ; Aguilar-Zanela, Lorena ; Castro-Oteo, Paola ; Rosales-Hernandez, Luis Adrian ; Otero-Mendoza, Francisco ; López-Herrera, Gabriela ; Ordoñez-Ortega, Javier ; Garrido-García, Martín ; Yamazaki-Nakashimada, Marco Antonio</creator><creatorcontrib>Rivas-Larrauri, Francisco ; Aguilar-Zanela, Lorena ; Castro-Oteo, Paola ; Rosales-Hernandez, Luis Adrian ; Otero-Mendoza, Francisco ; López-Herrera, Gabriela ; Ordoñez-Ortega, Javier ; Garrido-García, Martín ; Yamazaki-Nakashimada, Marco Antonio</creatorcontrib><description>Kawasaki disease (KD) has features that appear supporting an infectious cause with a secondary deranged inflammatory/autoimmune response. The association of KD in adults with human immunodeficiency virus infection and the presence of KD in patients with immunodeficiency disorders support the infectious theory. We present four KD patients associated with immunodeficiencies: one with X-linked agammaglobulinemia, one with HIV infection, and two with leukemia; one of these patients also had Down syndrome. We did a literature search to find out all reported cases of immunodeficiency with KD in children. In immunodeficiency disorders, the inability of the immune system to eradicate the pathogens coupled to an exaggerated inflammatory response, especially in chronic granulomatous disease, may lead to the development of KD. The study of patients with immunodeficiencies complicated with KD may shed light into the etiopathogenesis of the disease.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-019-04382-w</identifier><identifier>PMID: 31312887</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Agammaglobulinemia - complications ; Agammaglobulinemia - diagnosis ; Agammaglobulinemia - drug therapy ; Agammaglobulinemia - immunology ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Case Based Review ; Case reports ; Chemotherapy ; Child ; Child, Preschool ; Coronary vessels ; Down syndrome ; Down Syndrome - complications ; Erythema ; Fever ; Genetic Diseases, X-Linked - complications ; Genetic Diseases, X-Linked - diagnosis ; Genetic Diseases, X-Linked - drug therapy ; Genetic Diseases, X-Linked - immunology ; HIV ; HIV Infections - complications ; HIV Infections - diagnosis ; HIV Infections - drug therapy ; HIV Infections - immunology ; Human immunodeficiency virus ; Humans ; Immune system ; Immunocompromised Host ; Immunoglobulins ; Immunoglobulins, Intravenous - therapeutic use ; Infant ; Infections ; Kawasaki disease ; Laboratories ; Leukemia ; Leukemia - complications ; Leukemia - diagnosis ; Leukemia - drug therapy ; Leukemia - immunology ; Literature reviews ; Male ; Medicine ; Medicine & Public Health ; Mucocutaneous Lymph Node Syndrome - diagnosis ; Mucocutaneous Lymph Node Syndrome - drug therapy ; Mucocutaneous Lymph Node Syndrome - immunology ; Neutrophils ; Patients ; Pediatrics ; Rheumatology ; Risk Factors ; Treatment Outcome ; Ultrasonic imaging ; Veins & arteries</subject><ispartof>Rheumatology international, 2019-10, Vol.39 (10), p.1829-1838</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>Rheumatology International is a copyright of Springer, (2019). All Rights Reserved.</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-334ab57721f83077006e2ba1ef44725ff4c8b131998fe687d88af2f845b064973</citedby><cites>FETCH-LOGICAL-c403t-334ab57721f83077006e2ba1ef44725ff4c8b131998fe687d88af2f845b064973</cites><orcidid>0000-0001-7325-8801 ; 0000-0002-5505-9988 ; 0000-0002-9565-9072 ; 0000-0003-1398-0493 ; 0000-0001-5777-390X ; 0000-0002-7609-3923 ; 0000-0002-9964-7634 ; 0000-0002-2136-7165 ; 0000-0002-5498-6739</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00296-019-04382-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00296-019-04382-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31312887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivas-Larrauri, Francisco</creatorcontrib><creatorcontrib>Aguilar-Zanela, Lorena</creatorcontrib><creatorcontrib>Castro-Oteo, Paola</creatorcontrib><creatorcontrib>Rosales-Hernandez, Luis Adrian</creatorcontrib><creatorcontrib>Otero-Mendoza, Francisco</creatorcontrib><creatorcontrib>López-Herrera, Gabriela</creatorcontrib><creatorcontrib>Ordoñez-Ortega, Javier</creatorcontrib><creatorcontrib>Garrido-García, Martín</creatorcontrib><creatorcontrib>Yamazaki-Nakashimada, Marco Antonio</creatorcontrib><title>Kawasaki disease and immunodeficiencies in children: case reports and literature review</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><addtitle>Rheumatol Int</addtitle><description>Kawasaki disease (KD) has features that appear supporting an infectious cause with a secondary deranged inflammatory/autoimmune response. The association of KD in adults with human immunodeficiency virus infection and the presence of KD in patients with immunodeficiency disorders support the infectious theory. We present four KD patients associated with immunodeficiencies: one with X-linked agammaglobulinemia, one with HIV infection, and two with leukemia; one of these patients also had Down syndrome. We did a literature search to find out all reported cases of immunodeficiency with KD in children. In immunodeficiency disorders, the inability of the immune system to eradicate the pathogens coupled to an exaggerated inflammatory response, especially in chronic granulomatous disease, may lead to the development of KD. The study of patients with immunodeficiencies complicated with KD may shed light into the etiopathogenesis of the disease.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Agammaglobulinemia - complications</subject><subject>Agammaglobulinemia - diagnosis</subject><subject>Agammaglobulinemia - drug therapy</subject><subject>Agammaglobulinemia - immunology</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Case Based Review</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Coronary vessels</subject><subject>Down syndrome</subject><subject>Down Syndrome - complications</subject><subject>Erythema</subject><subject>Fever</subject><subject>Genetic Diseases, X-Linked - complications</subject><subject>Genetic Diseases, X-Linked - diagnosis</subject><subject>Genetic Diseases, X-Linked - drug therapy</subject><subject>Genetic Diseases, X-Linked - immunology</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - immunology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunocompromised Host</subject><subject>Immunoglobulins</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Infant</subject><subject>Infections</subject><subject>Kawasaki disease</subject><subject>Laboratories</subject><subject>Leukemia</subject><subject>Leukemia - complications</subject><subject>Leukemia - diagnosis</subject><subject>Leukemia - drug therapy</subject><subject>Leukemia - immunology</subject><subject>Literature reviews</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mucocutaneous Lymph Node Syndrome - diagnosis</subject><subject>Mucocutaneous Lymph Node Syndrome - drug therapy</subject><subject>Mucocutaneous Lymph Node Syndrome - immunology</subject><subject>Neutrophils</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Rheumatology</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Ultrasonic imaging</subject><subject>Veins & arteries</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kTlPxDAQhS0EguX4AxQoEg1NYHwkdujQiksg0YCgs5xkDIYci52w4t_jZTkkCgqPZc_33oz0CNmlcEgB5FEAYEWeAi1SEFyxdL5CJlRwmdIcHlbJBKhkqYplg2yG8AzxneewTjY45ZQpJSfk_srMTTAvLqldQBMwMV2duLYdu75G6yqHXTwhcV1SPbmm9tgdJ9UC9Djr_RA-BY0b0Jth9IvvN4fzbbJmTRNw5-veIndnp7fTi_T65vxyenKdVgL4kHIuTJlJyahVHKQEyJGVhqIVQrLMWlGpMi5bFMpirmStlLHMKpGVkItC8i1ysPSd-f51xDDo1oUKm8Z02I9BM5YVPFOFyCK6_wd97kffxe00ywshhYrgvxTLlFARXIxlS6ryfQgerZ551xr_rinoRTh6GY6O4ejPcPQ8iva-rMeyxfpH8p1GBPgSCLHVPaL_nf2P7Qcwa5kS</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Rivas-Larrauri, Francisco</creator><creator>Aguilar-Zanela, Lorena</creator><creator>Castro-Oteo, Paola</creator><creator>Rosales-Hernandez, Luis Adrian</creator><creator>Otero-Mendoza, Francisco</creator><creator>López-Herrera, Gabriela</creator><creator>Ordoñez-Ortega, Javier</creator><creator>Garrido-García, Martín</creator><creator>Yamazaki-Nakashimada, Marco Antonio</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7325-8801</orcidid><orcidid>https://orcid.org/0000-0002-5505-9988</orcidid><orcidid>https://orcid.org/0000-0002-9565-9072</orcidid><orcidid>https://orcid.org/0000-0003-1398-0493</orcidid><orcidid>https://orcid.org/0000-0001-5777-390X</orcidid><orcidid>https://orcid.org/0000-0002-7609-3923</orcidid><orcidid>https://orcid.org/0000-0002-9964-7634</orcidid><orcidid>https://orcid.org/0000-0002-2136-7165</orcidid><orcidid>https://orcid.org/0000-0002-5498-6739</orcidid></search><sort><creationdate>20191001</creationdate><title>Kawasaki disease and immunodeficiencies in children: case reports and literature review</title><author>Rivas-Larrauri, Francisco ; Aguilar-Zanela, Lorena ; Castro-Oteo, Paola ; Rosales-Hernandez, Luis Adrian ; Otero-Mendoza, Francisco ; López-Herrera, Gabriela ; Ordoñez-Ortega, Javier ; Garrido-García, Martín ; Yamazaki-Nakashimada, Marco Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-334ab57721f83077006e2ba1ef44725ff4c8b131998fe687d88af2f845b064973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Agammaglobulinemia - complications</topic><topic>Agammaglobulinemia - diagnosis</topic><topic>Agammaglobulinemia - drug therapy</topic><topic>Agammaglobulinemia - immunology</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Case Based Review</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Coronary vessels</topic><topic>Down syndrome</topic><topic>Down Syndrome - complications</topic><topic>Erythema</topic><topic>Fever</topic><topic>Genetic Diseases, X-Linked - complications</topic><topic>Genetic Diseases, X-Linked - diagnosis</topic><topic>Genetic Diseases, X-Linked - drug therapy</topic><topic>Genetic Diseases, X-Linked - immunology</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - immunology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunocompromised Host</topic><topic>Immunoglobulins</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Infant</topic><topic>Infections</topic><topic>Kawasaki disease</topic><topic>Laboratories</topic><topic>Leukemia</topic><topic>Leukemia - complications</topic><topic>Leukemia - diagnosis</topic><topic>Leukemia - drug therapy</topic><topic>Leukemia - immunology</topic><topic>Literature reviews</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mucocutaneous Lymph Node Syndrome - diagnosis</topic><topic>Mucocutaneous Lymph Node Syndrome - drug therapy</topic><topic>Mucocutaneous Lymph Node Syndrome - immunology</topic><topic>Neutrophils</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Rheumatology</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Ultrasonic imaging</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivas-Larrauri, Francisco</creatorcontrib><creatorcontrib>Aguilar-Zanela, Lorena</creatorcontrib><creatorcontrib>Castro-Oteo, Paola</creatorcontrib><creatorcontrib>Rosales-Hernandez, Luis Adrian</creatorcontrib><creatorcontrib>Otero-Mendoza, Francisco</creatorcontrib><creatorcontrib>López-Herrera, Gabriela</creatorcontrib><creatorcontrib>Ordoñez-Ortega, Javier</creatorcontrib><creatorcontrib>Garrido-García, Martín</creatorcontrib><creatorcontrib>Yamazaki-Nakashimada, Marco Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivas-Larrauri, Francisco</au><au>Aguilar-Zanela, Lorena</au><au>Castro-Oteo, Paola</au><au>Rosales-Hernandez, Luis Adrian</au><au>Otero-Mendoza, Francisco</au><au>López-Herrera, Gabriela</au><au>Ordoñez-Ortega, Javier</au><au>Garrido-García, Martín</au><au>Yamazaki-Nakashimada, Marco Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kawasaki disease and immunodeficiencies in children: case reports and literature review</atitle><jtitle>Rheumatology international</jtitle><stitle>Rheumatol Int</stitle><addtitle>Rheumatol Int</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>39</volume><issue>10</issue><spage>1829</spage><epage>1838</epage><pages>1829-1838</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>Kawasaki disease (KD) has features that appear supporting an infectious cause with a secondary deranged inflammatory/autoimmune response. The association of KD in adults with human immunodeficiency virus infection and the presence of KD in patients with immunodeficiency disorders support the infectious theory. We present four KD patients associated with immunodeficiencies: one with X-linked agammaglobulinemia, one with HIV infection, and two with leukemia; one of these patients also had Down syndrome. We did a literature search to find out all reported cases of immunodeficiency with KD in children. In immunodeficiency disorders, the inability of the immune system to eradicate the pathogens coupled to an exaggerated inflammatory response, especially in chronic granulomatous disease, may lead to the development of KD. The study of patients with immunodeficiencies complicated with KD may shed light into the etiopathogenesis of the disease.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31312887</pmid><doi>10.1007/s00296-019-04382-w</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7325-8801</orcidid><orcidid>https://orcid.org/0000-0002-5505-9988</orcidid><orcidid>https://orcid.org/0000-0002-9565-9072</orcidid><orcidid>https://orcid.org/0000-0003-1398-0493</orcidid><orcidid>https://orcid.org/0000-0001-5777-390X</orcidid><orcidid>https://orcid.org/0000-0002-7609-3923</orcidid><orcidid>https://orcid.org/0000-0002-9964-7634</orcidid><orcidid>https://orcid.org/0000-0002-2136-7165</orcidid><orcidid>https://orcid.org/0000-0002-5498-6739</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0172-8172 |
| ispartof | Rheumatology international, 2019-10, Vol.39 (10), p.1829-1838 |
| issn | 0172-8172 1437-160X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2259358945 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adrenal Cortex Hormones - therapeutic use Agammaglobulinemia - complications Agammaglobulinemia - diagnosis Agammaglobulinemia - drug therapy Agammaglobulinemia - immunology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Case Based Review Case reports Chemotherapy Child Child, Preschool Coronary vessels Down syndrome Down Syndrome - complications Erythema Fever Genetic Diseases, X-Linked - complications Genetic Diseases, X-Linked - diagnosis Genetic Diseases, X-Linked - drug therapy Genetic Diseases, X-Linked - immunology HIV HIV Infections - complications HIV Infections - diagnosis HIV Infections - drug therapy HIV Infections - immunology Human immunodeficiency virus Humans Immune system Immunocompromised Host Immunoglobulins Immunoglobulins, Intravenous - therapeutic use Infant Infections Kawasaki disease Laboratories Leukemia Leukemia - complications Leukemia - diagnosis Leukemia - drug therapy Leukemia - immunology Literature reviews Male Medicine Medicine & Public Health Mucocutaneous Lymph Node Syndrome - diagnosis Mucocutaneous Lymph Node Syndrome - drug therapy Mucocutaneous Lymph Node Syndrome - immunology Neutrophils Patients Pediatrics Rheumatology Risk Factors Treatment Outcome Ultrasonic imaging Veins & arteries |
| title | Kawasaki disease and immunodeficiencies in children: case reports and literature review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T13%3A57%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kawasaki%20disease%20and%20immunodeficiencies%20in%20children:%20case%20reports%20and%20literature%20review&rft.jtitle=Rheumatology%20international&rft.au=Rivas-Larrauri,%20Francisco&rft.date=2019-10-01&rft.volume=39&rft.issue=10&rft.spage=1829&rft.epage=1838&rft.pages=1829-1838&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-019-04382-w&rft_dat=%3Cproquest_cross%3E2258484747%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258484747&rft_id=info:pmid/31312887&rfr_iscdi=true |